Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.
Mutation in the ubiquitously expressed cytoplasmic superoxide dismutase (SOD1) causes an inherited form of Amyotrophic Lateral Sclerosis (ALS). Mutant synthesis in motor neurons drives disease onset and early disease progression. Previous experimental studies have shown that spinal grafting of human...
Main Authors: | Michael P Hefferan, Jan Galik, Osamu Kakinohana, Gabriela Sekerkova, Camila Santucci, Silvia Marsala, Roman Navarro, Marian Hruska-Plochan, Karl Johe, Eva Feldman, Don W Cleveland, Martin Marsala |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3423406?pdf=render |
Similar Items
-
Optimization of Immunosuppressive Therapy for Spinal Grafting of Human Spinal Stem Cells in a Rat Model of ALS
by: Michael P. Hefferan Ph.D., et al.
Published: (2011-09-01) -
Analysis of Dosing Regimen and Reproducibility of Intraspinal Grafting of Human Spinal Stem Cells in Immunosuppressed Minipigs
by: Dusan Usvald, et al.
Published: (2010-09-01) -
Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
by: Giada Cipollina, et al.
Published: (2020-10-01) -
Combinational spinal GAD65 gene delivery and systemic GABA-mimetic treatment for modulation of spasticity.
by: Osamu Kakinohana, et al.
Published: (2012-01-01) -
Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs
by: Atsushi Miyanohara, et al.
Published: (2016-01-01)